Login / Signup

Can we further optimize statin therapy to increase tolerability?

Massimiliano RuscicaZeljko ReinerCesare R Sirtori
Published in: Expert opinion on drug discovery (2019)
Keyphrases
  • cardiovascular disease
  • open label
  • coronary artery disease
  • type diabetes
  • stem cells
  • clinical trial
  • bone marrow
  • cell therapy
  • study protocol
  • smoking cessation